Zura Bio Q4 EPS $(0.30) Misses $(0.23) Estimate
Portfolio Pulse from Benzinga Newsdesk
Zura Bio reported a Q4 EPS loss of $(0.30), missing the consensus estimate of $(0.23) by 30.43%.
March 28, 2024 | 12:22 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Zura Bio reported a larger than expected Q4 loss per share of $(0.30), missing the consensus estimate of $(0.23).
Missing earnings estimates, especially by a significant margin such as 30.43%, typically leads to negative investor sentiment and can result in a short-term decline in stock price. Investors and analysts may adjust their expectations and valuations based on this new information, potentially leading to a sell-off.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100